InvestorsHub Logo
Followers 138
Posts 79642
Boards Moderated 5
Alias Born 01/22/2007

Re: MDPennyPlayer post# 64895

Monday, 02/05/2024 3:56:28 PM

Monday, February 05, 2024 3:56:28 PM

Post# of 65575
another RED Flag debunked....and anmazing you never go back and correct your b/s...

Wait until people realize SHMN showing off at these conferences in the spring is just them buying a ticket and attending.

They don't have an exhibit or are they speaking about ABBIE during the conference.




SOHM, Inc.
@sohminc
We are excited to announce that our company will participate in the American Association for Cancer Research (AACR) annual meeting in San Diego from April 5 to April 10, 2024.

At this internationally attended meeting, we will present our innovative gene-editing system, ABBIE, and its potential in cancer research to the scientific community and media covering the conference.

The abstract of our poster presentation will be published on the AACR website (http://aacr.org) on March 22, 2024.

Our preliminary focus in this project is cancer, but our technology has utilities in many areas of medicine and bioscience where genome editing has great potential. As we progress in this work, we plan to add highly significant research and product developments for various industries in biotech, medicine and agriculture.

We are very proud of our company’s progress to date, our entire research team, including but not limited to Dr. David Aguilar, PhD and our Research Scientist, Alfred Gallegos, and our contributions to genome editing, cell engineering, and the biomedical and other biotech sectors.

Baron Night
CEO
$SHMN
Bullish
Bullish